BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmidt FM, Brügel M, Kratzsch J, Strauß M, Sander C, Baum P, Thiery J, Hegerl U, Schönknecht P. Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neuroscience Letters 2010;483:20-2. [DOI: 10.1016/j.neulet.2010.07.038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Lu J, Li S, Huang B, Shi G, Mou T, Xu Y. Increased Hypocretin (Orexin) Plasma Level in Depression, Bipolar Disorder Patients. Front Psychiatry 2021;12:676336. [PMID: 34135789 DOI: 10.3389/fpsyt.2021.676336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H. Reduced plasma orexin-A levels in patients with bipolar disorder. Neuropsychiatr Dis Treat 2019;15:2221-30. [PMID: 31496705 DOI: 10.2147/NDT.S209023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
3 Sargin D. The role of the orexin system in stress response. Neuropharmacology 2019;154:68-78. [PMID: 30266600 DOI: 10.1016/j.neuropharm.2018.09.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
4 Nollet M, Leman S. Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention. CNS Drugs 2013;27:411-22. [DOI: 10.1007/s40263-013-0064-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
5 Lungwitz EA, Molosh A, Johnson PL, Harvey BP, Dirks RC, Dietrich A, Minick P, Shekhar A, Truitt WA. Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiol Behav 2012;107:726-32. [PMID: 22652097 DOI: 10.1016/j.physbeh.2012.05.019] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 6.8] [Reference Citation Analysis]
6 Dauvilliers Y, Lopez R, Ohayon M, Bayard S. Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med 2013;11:78. [PMID: 23514569 DOI: 10.1186/1741-7015-11-78] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
7 Treu SP, Plante DT. Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis. Sleep Med 2021;85:230-8. [PMID: 34364094 DOI: 10.1016/j.sleep.2021.07.007] [Reference Citation Analysis]
8 Hsu CW, Wang S. Changes in the Orexin System in Rats Exhibiting Learned Helplessness Behaviors. Brain Sci 2021;11:1634. [PMID: 34942932 DOI: 10.3390/brainsci11121634] [Reference Citation Analysis]
9 Pizza F, Magnani M, Indrio C, Plazzi G. The hypocretin system and psychiatric disorders. Curr Psychiatry Rep 2014;16:433. [PMID: 24363104 DOI: 10.1007/s11920-013-0433-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
10 Akça ÖF, Sağlam E, Kılınç I, Bilgiç A. Orexin a levels of adolescents with major depressive disorder. Int J Psychiatry Clin Pract 2021;:1-4. [PMID: 34032542 DOI: 10.1080/13651501.2021.1927106] [Reference Citation Analysis]
11 Schönknecht P, Anwander A, Petzold F, Schindler S, Knösche TR, Möller HE, Hegerl U, Turner R, Geyer S. Diffusion imaging-based subdivision of the human hypothalamus: a magnetic resonance study with clinical implications. Eur Arch Psychiatry Clin Neurosci 2013;263:497-508. [PMID: 23287964 DOI: 10.1007/s00406-012-0389-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rotter A, Asemann R, Decker A, Kornhuber J, Biermann T. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder. Journal of Affective Disorders 2011;131:186-92. [DOI: 10.1016/j.jad.2010.12.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
13 Khairuddin S, Aquili L, Heng BC, Hoo TLC, Wong KH, Lim LW. Dysregulation of the orexinergic system: A potential neuropeptide target in depression. Neuroscience & Biobehavioral Reviews 2020;118:384-96. [DOI: 10.1016/j.neubiorev.2020.07.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology. Pharmacol Rev 2012;64:389-420. [DOI: 10.1124/pr.111.005546] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 11.4] [Reference Citation Analysis]
15 Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauß M, Baum P, Hegerl U, Schönknecht P. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Research 2011;190:240-3. [DOI: 10.1016/j.psychres.2011.06.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
16 Katzman MA, Katzman MP. Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone. Brain Sciences 2022;12:150. [DOI: 10.3390/brainsci12020150] [Reference Citation Analysis]
17 Shariq AS, Rosenblat JD, Alageel A, Mansur RB, Rong C, Ho RC, Ragguett R, Pan Z, Brietzke E, Mcintyre RS. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;92:1-7. [DOI: 10.1016/j.pnpbp.2018.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
18 Ozsoy S, Olguner Eker O, Abdulrezzak U, Esel E. Relationship between orexin A and childhood maltreatment in female patients with depression and anxiety. Social Neuroscience 2016;12:330-6. [DOI: 10.1080/17470919.2016.1169216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]